Joined Nov 11, 2007
31,929 Blog Posts

$JNJ Does Not Get FDA Approval for Blood Thinner

“The U.S. Food and Drug Administration (FDA) last night rejected an application from Johnson & Johnson (NYSE: JNJ) and Germany’s Bayer A.G. to extend the use of the two companies’ blood thinning drug Xarelto for reducing risk of heart attacks and strokes in patients with chest pain or previous cardiac illness. The drug was approved in 2011 for use to prevent clotting during some joint replacement surgeries, and its use has been expanded to treat irregular heartbeats and other types of blood clots….”

Full article

If you enjoy the content at iBankCoin, please follow us on Twitter